Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
The chart shows bullish engulfing pattern as of now. The stock is rebounding from the bottom. It is turning bullish. Next hit point is 28.77.
U.S. stock markets closed lower, with $Dow Jones Industrial Average (.DJI.US)$ falling by 0.44% to 33,585.00. The day’s losses were driven by declines in key sectors such as healthcare and aerospace, with $Merck & Co (MRK.US)$ down 1.70%, $Boeing (BA.US)$ losing 1.55%, and $Amazon (AMZN.US)$ declining 1.52%. Meanwhile, technology stocks managed to post gains, with $Salesforce (CRM.US)$ rising 0.51% and $Chevron (CVX.US)$ climbing ...
The chart shows a hammer as of now. The stock has hit the bottom and should see bottom reversal soon.
Just added some shares at 28.33, 28.35, 28.39 and 28.44 to DCA. Cheap to accumulate.
Start Reversal to 120
No comment yet